Skip to main content
. 2022 May 30;22:168. doi: 10.1186/s12871-022-01707-4

Table 1.

Patient demographic and clinical characteristics

Characteristics Group US
(n = 97)
Group FOB
(n = 98)
p-value
Baseline characteristics
 Age (yrs) 60.4 ± 15.6 60.6 ± 12.8 0.93
 Male gender 38 (39.2%) 48 (49.0%) 0.19
 Height (cm) 158 ± 8.8 160 ± 7.8 0.16
 Weight (kg) 61.4 ± 10.9 62.1 ± 12.7 0.65
 Body mass index (kg/m2) 24.4 ± 4.4 24.0 ± 4.3 0.58
 ASA physical status 0.12
  1 5 (5.2%) 11 (11.2%)
  2 59 (60.8%) 64 (65.3%)
  3 33 (34.0%) 23 (23.5%)
Primary diagnosis 0.64
 Lung nodule/mass 59 (60.8%) 65 (66.3%)
 Lung cancer 24 (24.7%) 25 (25.5%)
 Lung bleb 1 (1.0%) 0 (0.0%)
 Pneumothorax (minimal residual air) 2 (2.1%) 1 (1.0%)
 Others 11 (11.3%) 7 (7.1%)
Comorbidity
 Diabetes mellitus 18 (18.6%) 13 (13.3%) 0.34
 Hypertension 54 (55.7%) 38 (38.8%) 0.02
 Dyslipidemia 19 (19.6%) 18 (18.4%) 0.86
 Other 24 (24.7%) 14 (14.3%)
Type of surgery 0.60
 Video-assisted thoracoscopic surgery 73 (75.3%) 74 (75.5%)
 Thoracotomy 24 (24.7%) 23(23.5%)
 Median sternotomy 0 (0.0%) 1 (1.0%)
Size of double lumen tube 0.38
 32 4 (4.1%) 3 (3.1%)
 35 56 (57.7%) 48 (49.0%)
 37 37 (38.1%) 47 (48.0%)

Data presented as number and percentage or mean ± standard deviation

A p-value < 0.05 indicates statistical significance

Abbreviations: US ultrasonography, FOB fiberoptic bronchoscopy, ASA American Society of Anesthesiologists